2
in the work. Government sanctioned the scheme and work was commenced in
August 1919. The training of the existing staff, who were not acquainted with
the special methods necessary for manufacture on a large scale, and of the new
hands occupied some time. As these became proficient, the extended manufacture
of the vaccine was taken in hand and the required quantity was prepared in time
to meet all the demands which were received during the past cold weather. In
all 427,063 c.cs. have been made of which 35,499 c.cs. have already been issued.
The remainder together with 74,650 c.cs. purchased from the Central Research
Institute, Kasauli,before the output from the Institute was assured is at present
in cold store ready for immediate issue should occasion demand.
A considerable increase in the issue of prophylactic cholera vaccine occa
- s i o n e d b y t h e d e s i r e o f G o v e r n m e n t t o e n c o u r a g e t h e u s e o f t h i s v a c c i n e h a s a l s o
been a feature of the year. The output necessary to meet the increased demands
has been rendered possible by the employment of the staff engaged in vaccine
production on the manufacture of this vaccine also.
45,455 c.cs. have been supplied this year to the civil department as opposed
to 352 c.cs. issued during the year 1918.
Other vaccines have also been made but not on the same scale; the quantities
of these issued are shown in Table II.
TABLE II.
Vaccines supplied in 1919.
N u m b e r .
Nature of vaccine.
Number of doses
of autogenous
vaccine.
Number of doses
of stock vaccine.
Total.
1 Staphylococcus . . .
380
1,031
1,411
2 Streptococcus . . .
326
398
724
3
A c n e b a c i l l u s . . .
. . .
82
82
4 Streptococcus for cases of pemphigus . . .
24
158
182
5 Gonococcus . . .
9
5,771
5,780
6 P n e u mo c o c c u s . . .
96
100
196
7 B. Influenzæ (curative) . . .
32
530
562
8
Do. (prophylactic) . . .
. . .
35,499
35,499
9 Compound catarrhal vaccine . . .
140
59
199
10 Tuberculin . . .
. . .
1,477
1,477
11 B. Coli. . .
40
41
81
12 B. Dysenteriæ . . .
. . .
150
150
13 V. Choleræ . . .
. . .
47,545
47,545
14 B. Typhosus . . .
. . .
235
235
15 T.A.B. vaccine . . .
. . .
4,096
4,096
16 Other vaccines . . .
4 8
. . .
48
Total . . .
1,095
97,172
98,267
Reports on the use of the different stock vaccines.
Staphylococcus vaccine was apparently used with benefit in cases of furun
- c u l o s i s , c a r b u n c l e s , i s c h i o r e c t a l a b s c e s s , c e l l u l i t i s o f t h e f o o t , p u e r p e r a l s e p s i s ,
empyema, etc.
Streptococcus vaccine was found useful in cases of puerperal sepsis, phlegmasia
dolens and erysipelas. The "pemphigus streptococcus vaccine" was used with
benefit in cases of eczema and pustular eruptions.
The stock acne vaccine of the Institute was reported upon favourably in a few
cases.
The compound catarrhal vaccine of the Institute containing pneumococcus,
B. influenzæ and M. catarrhalis was found to be useful in a few cases of
bronchitis.
A curative influenza vaccine, containing 3 million B. influenzæ and 10 million
pneumococci per c.c., was issued for trial in cases of influenza, especially those
of a chronic nature. The general concensus of opinion appears to be that no
appreciable benefit was derived from its use. At the Central Jail at Trichinopoly
the experience gained from cases treated with the curative injections and those